Golda MV > Ọgwụ

Ọgwụ dị n'ụdị mbadamba ụrọ nke nwere ndọtị agbanwere: ọcha ma ọ bụ ọcha nwere obere odo, okirikiri, ewepụghị-cylindrical, nwere bevel, na mbadamba ụrọ nwere 60 mg enwere ihe ọghọm nke iche (maka onunu ogwu nke 30 mg: 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 150, 180, 200 ma ọ bụ pọọsụ 300. Na Mkpọ, na ngwungwu bọọlụ 1 nwere ike, pọọsụ 10. N'ime ngwugwu na-acha uhie uhie, na ngwungwu mkpọ 1-10, maka usoro onunu ogwu 60 mg: 10, 20, 25, 30, 40, 50, 60, 70, 75, 80, 84, 90, 100, 120, 125, 140, 150, 180, 250, ma ọ bụ 300 pọọsụ na ite, n’ime igbe kaadi. 1 nwere ike, na ngwugwu ọnya: 10 pcs., Per Mpempe akwụkwọ mkpọ 1-10, 7 pc., n'ime mkpọ katọn 2, 4, 6, 8 ma ọ bụ mkpọ 10. Pack nke ọ bụla nwekwara ntuziaka maka iji Golda MV).

Otu mbadamba 1 nwere:

ihe na-arụ ọrụ: gliclazide - 30 ma ọ bụ 60 mg,
ihe inyeaka: lactose monohydrate, sodium carboxymethyl stachi (ụdị C), hypromellose 2208, colloidal silicon dioxide, magnesium stearate.

Mlọ ọgwụ

Golda MV bụ ọgwụ ọnụ hypoglycemic ọgwụ. Gliclazide, ihe eji arụ ọrụ ya, bụ ihe ewepụtara iji wepụta sulfonylurea nke ọgbọ nke abụọ. Apụrụ iche site na ọgwụ ndị yiri ya site na ọnụnọ nke nwere heterocyclic ring N-nwere nke njikọ endocyclic. Glyclazide na-akpali mkpali insulin site na mkpụrụ ndụ beta nke agwaetiti nke Langerhans, na -ebelata nchịkọta nke glucose n'ọbara. Mgbe afọ abụọ nke ọgwụgwọ gasịrị, mmetụta nke ịba ụba ịbawanye uru nke insprandial insulin na C-peptide na-adịgide.

Tinyere nsonaazụ metabolism, ọ nwere mmetụta haemovaskụla. N'ime ụdị ọrịa shuga abụọ nke mellitus, gliclazide na-enyere aka weghachite mbido mbụ nke insulin na nzaghachi na glucose ma na-eme ka akụkụ nke abụọ nke insulin na-arụ ọrụ ike. A na - eme ka insulin na - agbasawanye nke ọma na nzụlite n'ihi nri nri na nchịkwa glucose.

A na-egosipụta mmetụta hemovaskụla nke gliclazide site na mbelata nke obere mkpụrụ osisi thrombosis. Akụkụ nke obere na-egbochi nchịkọta platelet na nrapado, na-ebelata ọkwa nke itinye ihe n'ọrụ platelet (thromboxane B2, beta-thromboglobulin). Na-enyere aka iwelie ọrụ nke plasminogen activates anụ ahụ, nwere mmetụta na mweghachi nke ọrụ fibrinolytic nke vaskụla endothelium.

N'ime ndị ọrịa nwere gemocemic haemoglobin (Hb_A1c) ihe na-erughị 6.5%, iji gliclazide na-enye nchịkwa glycemic siri ike, na-ebelata nnukwu micro- na macro-vaskụla nsogbu nke ụdị shuga 2.

Ebumnuche nke gliclazide maka ebumnuche nke nchịkwa glycemic siri ike gụnyere ịbawanye ọgwụ ya na mgbakwunye na usoro ọgwụgwọ (ma ọ bụ kama ya) tupu ịgbakwunye metformin, ihe nrịba nke thiazolidinedione, onye na-egbochi alpha-glucosidase, insulin ma ọ bụ onye nnọchianya hypoglycemic ọzọ na ya. Nsonaazụ nke ihe omumu emere gosiputara na n’egbochi ojiji nke gliclazide n’ime nkezi kwa ubochi nke 103 mg (nke kachasi - 120 mg) ma e jiri ya tufuo ihe nlebara anya, onodu ojoo nke otutu anakpo macro-na microvascular na-ebelata 10%.

Abamuru nke njikwa glycemic kpụ ọkụ n'ọnụ mgbe ị na-ewere Golda MV gụnyere mbelata nke ukwuu gbasara ọrịa dịka nnukwu nsogbu microvascular (site na 14%), nephropathy (site na 21%), nsogbu gbasara akụrụ (11%), microalbuminuria (na 9%) , macroalbuminuria (30%).

Mlọ ọgwụ

Mgbe a natasịrị Golda MV ọnụ, glycazide na-etinye obi gị dum, ọkwa plasma ya na-ebili nwayọ wee ruo na awa 6-12. Nri oriri na-eme ya n'otu oge anaghị emetụta ogo mmịpụta, mgbanwe nke onwe onye bụ nke ọma. Ejiri Gliclazide n’ime ihe ruru 120 mg na-egosi mmekọrịta dị n’etiti ọgwụ a nabatara na AUC (mpaghara ahụ n’okpuru oge ịacụ ọgwụ nke oge).

Indmegide protein ndị dị na plasma ọbara - 95%.

Olu nke nkesa dị ihe dịka 30 lita. Otu gliclazide na - achi achi na a na - etinye ike itinye uche ya na plasma ọbara ihe karịrị awa 24.

Gliclazide bụ metabolized n'ime imeju. Enweghị metabolites na-arụ ọrụ na plasma ọbara.

Iwepu ọkara ndụ bụ awa 12-20.

A na - ekeji ya kachasị site na akụrụ n'ụdị metabolites, na - agbanweghi - erughi 1%.

N'ime ndị ọrịa merela agadi, a naghị atụ anya mgbanwe dị ukwuu na ọgwụ ọgwụ.

Ihe ngosi maka ojiji

ọgwụgwọ ụdị ọrịa shuga mellitus nke 2 - na enweghị mmetụta zuru oke nke usoro ọgwụgwọ nri, mmega ahụ na oke ibu,
igbochi nsogbu nke ndị ọrịa nwere ụdị ọrịa shuga 2 - na -ebelata ihe ize ndụ nke microvascular (retinopathy, nephropathy) na ọrịa macrovascular (infarction myocardial infarction, stroke) site na nchịkwa glycemic kpụ ọkụ n'ọnụ.

Ihe ngbanwe

ụdị shuga 1
mamịrị precca, mamịrị shuga,
ọrịa mamịrị ketoacidosis,
nnukwu nsogbu gbasara akwara,
oke umeji akwara,
concomitant ọgwụ na miconazole,
ngwakọta ọgwụgwọ na danazol ma ọ bụ phenylbutazone,
na -agaghị agagide nwoke nke lactose, galactosemia, glucose-galactose malabsorption,
oge ime
inye ara
afọ ruo afọ 18
onye anabataghi ihe mmadu si na sulfonialurea, sulfonamides,
hypersensitivity na mmiri ọgwụ.

Ekwesịrị iji mbadamba ọla edo na-eji nlezianya mee ihe na ndị agadi nwere nsogbu na-adịghị ala ala na / ma ọ bụ nri na-edozi ahụ, ọrịa siri ike nke akwara obi (ọrịa obi na-efe efe, atherosclerosis zuru ebe niile, nnukwu carotid arteriosclerosis), glucose-6-phosphate dehydrogenase erughi, akụrụ na / ọdịda imeju, adrenal ma ọ bụ nkụda ume, hypothyroidism, ọgwụgwọ ogologo oge na glucocorticosteroids (GCS), ahoụrụma.

Golda MV, ntuziaka maka ojiji: usoro na usoro onunu ogwu

Ana aralara mbadamba mbadamba ọla edo MV, na-elo ihe niile (na-enweghị atụ), ọkacha mma n'oge nri ụtụtụ.

A na-ewere kwa ụbọchị otu ugboro ma kwesiri ịdị n’etiti site na 30 ruo 120 mg.

Nweghi ike itughari udiri ọgwụ ọzọ na mberede, na-a anụ ọgwụ ọ increasedụ .ụ.

A na-ahọrọ dose nke gliclazide n'otu n'otu, na-eburu n'uche ọkwa nke itinye glucose na ọbara na ntanye Hb._A1c.

Usoro ọgwụgwọ akwadoro: usoro mbido bụ 30 mg (1 mbadamba ọla edo MV 30 mg ma ọ bụ ½ Gold MV 60 mg). Ọ bụrụ na usoro egosipụtara na-enye njikwa glycemic zuru oke, mgbe ahụ enwere ike iji ya dịka ọgwụ mmezi. Na enweghị mmetụta ọgwụgwọ zuru oke mgbe ụbọchị 30 nke ọgwụgwọ gasịrị, a na-eji nwayọọ nwayọọ na-abawanye nke mbido 30 mg (ruo 60, 90, 120 mg). N'ọnọdụ ndị ọzọ, ọ bụrụ na ọkwa glucose onye ọrịa agbadatala mgbe ụbọchị 14 nke ọgwụgwọ gasịrị, ị nwere ike ịga n’ihu ịbawanye usoro ahụ ụbọchị iri na anọ mgbe mmalite nke nchịkwa.

Ogo kachasị nke ụbọchị bụ 120 mg.

Mgbe ị na-agbanwe site na iwere mbadamba ihe glyclazide ozugbo na 80 mg, malite na mbadamba mbugharị gbanwetụrụ kwesịrị ịmalite na 30 mg, na-esochi ọgwụgwọ jiri njikwa glycemic.

Mgbe ị na-eji ọgwụ hypoglycemic na-agagharị na Golda MV, a naghị achọ oge ntụgharị. Uzo mbu nke gliclazide na mbadamba ihe eji emeghari kwesiri ibu 30 mg, ntinye ya na-adabere n’onodu gululu n’ime obara.

Mgbe ị na-atụgharị okwu, ekwesịrị ị doseụ ọgwụ ahụ na ọkara ndụ nke hypoglycemic ọgwụ gara aga. Ọ bụrụ na etinyere ihe ndị na-enye sulfonylurea na ndụ ogologo ndụ, mgbe ahụ, enwere ike ịkwụsị hypoglycemic nke ndị na-elekọta hypoglycemic niile ruo ọtụtụ ụbọchị. Nke a ga - ezere hypoglycemia n'ihi mmetụta mgbakwunye nke glycoslazide na usoro sulfonylurea.

E gosipụtara ojiji nke Golda MV na njikọta ọgwụ mgbochi na alfa-glucosidase inhibitors, biguanides ma ọ bụ insulin.

Ọrịa ndị okenye (karịrị 65), anaghị achọ mmegharị dose.

Na ọdịda obere mkpụmkpụ akwara na-agafe agafe, a chọghị ịmegharị dose.

A na-atụ aro ka iji obere grylazide dị ntakịrị (30 mg) nke na-arụ ọrụ ogologo oge maka ọgwụgwọ nke ndị ọrịa n'ihe ize ndụ nke ịmalite hypoglycemia, nri na-adịghị mma ma ọ bụ nke na-adịghị edozi ahụ, nkwarụ endocrine siri ike ma ọ bụ nke na-adịghị mma, hypothyroidism, ọrịa siri ike nke usoro obi, oge ejiri ogologo oge iji na / ma ọ bụ nchịkwa na usoro ọgwụgwọ dị elu. glucocorticosteroids (GCS).

Ojiji nke Golda MV na mgbakwunye na nri na mmega iji gbochie nsogbu nke ịrịa ọrịa shuga 2 kwesịrị iji ọgwụ 30 mg. Iji mezuo nchịkwa glycemic siri ike ma zube ọkwa Hb_A1c enwere ike ịbawanye ọgwụ nke mbụ ruo ogo nke 120 mg kwa ụbọchị. Ebumnuche nke ọgwụ maka nchịkwa glycemic siri ike na-egosipụta na ngwakọta na metformin, inhibitor alpha-glucosidase, ọgwụ thiazolidinedione, insulin na ndị ọzọ hypoglycemic.

Nsonaazụ

Site na nchefu nke nri na-esote ma ọ bụ iri nri oge adịghị mma, ihe mgbaàmà ndị na-esonụ nke hypoglycemia nwere ike pụta: ike ọgwụgwụ, agụụ siri ike, isi ọwụwa, mmeghachi omume oge, ọgbụgbọ, ọgbụgbọ, ndọta, ọgbụgba, adịghị ike, nsogbu ụra, iwe, mgbakasị ahụ, ọgba aghara, ọgba aghara, ịda mba, ọhụhụ na anya na okwu, paresis, aphasia, jijiji, ọnwụ nke njide onwe onye, nghọta zuru oke, mmetụta nke enweghị enyemaka, mgbakasị ahụ, iku ume dị ala, bradycardia, delirium, ura. st, ọnwụ nke nsụhọ, amaghị onwe (gụnyere egbu), adrenergic nzaghachi - ụba sweating, nchegbu, clammy akpụkpọ ahụ, tachycardia, mụbara ọbara mgbali (ọbara mgbali), arrhythmia, palpitations, rịaworo pectoris. Nsonaazụ nke ọmụmụ ọmụmụ na-egosi na mgbe ị na-eji ọgwụ ahụ maka ebumnuche nke nchịkwa glycemic siri ike, hypoglycemia na-eme ọtụtụ ugboro karịa na njikwa glycemic ọkọlọtọ. Ọtụtụ ikpe nke hypoglycemia na oke nchịkwa glycemic mere megide mmalite nke usoro ọgwụgwọ insulin.

Na mgbakwunye, megide ndabere nke iji Golda MV, mmetụta ndị na-esonụ nwere ike ịmalite:

site na eriri afọ: mgbu afọ, ọgbụgbọ, vomiting, afọ ọsịsa, afọ ntachi,
sitere na sistemmuzu ọbara na okirikiri: ọ na - adịkarị - thrombocytopenia, anaemia, leukopenia, granulocytopenia,
site na sistemu ịba ọcha n'anya: ụba ọrụ alkaline phosphatase, ACT (aspartate aminotransferase), ALT (alanine aminotransferase), ịba ọcha n'anya, cholestatic jaundice,
n'akụkụ akụkụ ahụ nke ọhụụ: ọgba aghara a na-ahụ anya n'oge (karịa mgbe ọ bụla na mmalite ọgwụgwọ),
mmeghachi omume nke akpịrị ịkpọ nkụ: itching, fash, maculopapular fash, urticaria, erythema, ede ede Quincke, mmeghachi omume jọgburu onwe (gụnyere Stevens-Johnson syndrome, necrolysis na-egbu egbu),
ihe ndi ozo (ihe ndi ozo akparamagwa nke ihe oma di na sulfonylurea): haemolytic anaemia, erythrocytopenia, agranulocytosis, vasculitis allergies, pancytopenia, hyponatremia, jaundice, imeju nke ukwu.

Dodoụbiga ya ókè

Mgbaàmà: na ịdoụbiga ya ókè, a na-egosipụta njirimara nke hypoglycemia.

Ọgwụgwọ: ịkwụsị mgbaàmà nke hypoglycemia (na-enweghị mgbaàmà akwara ozi na nsụsị mmụọ), ọ dị mkpa ịbawanye iri nri carbohydrate, belata dose nke Golda MV na / ma ọ bụ gbanwee nri. E gosipụtara nleba anya nyocha ahụike nke ọnọdụ onye ọrịa

Site na ngosipụta nke ọnọdụ hypoglycemic siri ike (coma, nkwarụ na nsogbu ndị ọzọ sitere na akwara ozi), a chọrọ ụlọ ọgwụ ozugbo.

Nlekọta ahụike mberede maka hypoglycemic coma ma ọ bụ inyo ya enyo na ntinye (iv) ntụtụ nke 20-30% dextrose (glucose) na ntụtụ nke 50 ml, nke na-esote iv dopesrose 10%, nke na-ejigide ọkwa glucose na ọbara dị elu karịa 1 g / l. Ekwesịrị iji nlezianya na-achọpụta ọnọdụ onye ọrịa na ileba anya itinye uche glucose ọbara maka awa 48 na-esote.

Dialysis adighi ike.

Ntụziaka pụrụ iche

Ekwesịrị ịnye Golda MV naanị ma ọ bụrụ na nri onye ọrịa gụnyere nri ụtụtụ, yana nri na-edozi ahụ mgbe niile. Ejikọtara nke a na nnukwu ihe egwu nke ịmalite hypoglycemia, gụnyere ụdị siri ike ma dị ogologo nke chọrọ ụlọ ọgwụ na nchịkwa ivosé dextrose maka ọtụtụ ụbọchị. N'oge ị na-enweta Golda MV, ọ dị ezigbo mkpa iji hụ na nri batrị zuru oke na ahụ. Oriri na-adịkarị kwa ụbọchị, oriri na-ezughị ezu, ma ọ bụ nri na-adịghị mma nke carbohydrate nwere ike ibute hypoglycemia. Ọtụtụ mgbe, a na-ahụ mmepe mmepe nke hypoglycemia na ndị ọrịa na-agbaso nri kalori, mgbe ọ gbasịrị ume ma ọ bụ ogologo oge, na-a alcoholụ mmanya ma ọ bụ mgbe ị na-emeso ọtụtụ ndị ọrụ hypoglycemic n'otu oge. Ọtụtụ mgbe, nri ndị nwere carbohydrate (gụnyere shuga) nwere ike inye aka belata ihe mgbaàmà hypoglycemia. N'okwu a, nnọchi shuga adịghị arụ ọrụ. Okwesiri iburu n'uche na hypoglycemia nwere ike ịmaliteghachi. Yabụ, ọ bụrụ na hypoglycemia nwere ọrịa akpọrọ ma ọ bụ ọdịdị ogologo oge, agbanyeghị arụ ọrụ nke iri nri nwere carbohydrate, ịkwesịrị ịchọ enyemaka ahụike mberede.

Mgbe ị na-ahọpụta Golda MV, dọkịta kwesịrị ịkọtara onye ọrịa ahụ n'ụzọ zuru ezu banyere usoro ọgwụgwọ yana mkpa ọ dị ịgbasochi usoro dosing, nri kwesịrị ekwesị na mmega ahụ.

Ihe kpatara mmepe hypoglycemia bụ enweghi ike ma ọ bụ enweghị ike onye ọrịa (ọkachasị na ịka nká) ịgbaso ndụmọdụ ndị dọkịta ma na-achịkwa usoro shuga dị n'ọbara, nri na-ezighi ezi, mgbanwe nri, nri iri nri ma ọ bụ agụụ, enweghị atụ n'etiti ọrụ mmega ahụ na oke carbohydrates iwere, nnukwu ọrịa imeju. , ọdịda akụrụ, ị drugụ ọgwụ gabigara ókè, pituitary na adrenal insufficiency na / ma ọ bụ ọrịa thyroid.

Na mgbakwunye, hypoglycemia nwere ike ime ka mmekọrịta nke gliclazide nwee ọgwụ ọgwụ concomitant. Ya mere, onye ọrịa ahụ kwesịrị ịnabata dọkịta ọ bụla na ị takingụ ọgwụ ọ bụla.

Mgbe ị na-ahọpụta Golda MV, dọkịta kwesịrị ịgwa onye ọrịa ahụ na ndị ezinụlọ ya n'ụzọ zuru ezu banyere ihe ọghọm na uru nke ọgwụgwọ na-abịanụ, ihe kpatara ya na mgbaàmà hypoglycemia, mkpa ọ dị ịgbaso usoro nri a tụrụ aro ya na otu usoro mmega ahụ, ọ ga-ekwe omume njikwa onwe onye mgbe niile nke ọkwa glucose ọbara.

Iji nyochaa njikwa glycemic, Hb kwesịrị ịtụle oge niile._Alc.

Okwesiri iburu n’uche na site na ọrịa ịba ọcha n’anya na / ma ọ bụ ọdịda akụrụ ala, enwere ike ịgbatị ọnọdụ nke hypoglycemia ma chọọ ọgwụgwọ kwesịrị ekwesị ozugbo.

Enwere ike ịmetụta njikwa glycemic ahụ site na nrịanrịa, ọrịa na-efe efe, mmerụ ahụ ma ọ bụ nnukwu ịwa ahụ. N'ime ọnọdụ ndị a, ọ dị mma ịnyefe onye ọrịa na ọgwụ insulin.

Enweghi ike nke gliclazide mgbe ogologo oge ọgwụgwọ nwere ike ịbụ n'ihi ọgwụ mgbochi nke abụọ, nke bụ nsonazụ nke ọrịa ahụ ma ọ bụ mbelata nzaghachi ọgwụ banyere ọgwụ. Mgbe ị na-achọpụta ọgwụ mgbochi nke abụọ, ọ dị mkpa iji hụ na onye ọrịa ahụ na-agbasoro usoro nri etinyere ma chọpụta nzipu nke oke nke Golda MV ewere.

Site na ụkọ glucose-6-phosphate dehydrogenase, iji usoro sulfonylurea na-abawanye ohere ịba ọcha n'anya hemolytic. Ya mere, maka ịgwọ ndị ọrịa nwere ụkọ glucose-6-phosphate dehydrogenase, a ga-ahọrọ ndị hypoglycemic ndị na-ahụ maka otu ọzọ.

Mkparịta ụka ọgwụ ọjọọ

miconazole: nhazi sistemụ nke miconazole ma ọ bụ ojiji ya n'ụdị nke jeliki na mucosa a na-ebute na-akpata mmụba na hypoglycemic mmetụta nke gliclazide, nke nwere ike ibute mmepe nke hypoglycemia ruo coma,
phenylbutazone: nchikota ya na ụdị okike nke phenylbutazone na - akwalite mmetụta hypoglycemic nke Golda MV, yabụ, ọ bụrụ na ọ gaghị ekwe omume ị presụ ọgwụ mgbochi mbufụt ọzọ, ọ dị mkpa iji dozie dose nke glyclazide ma n'oge nchịkwa nke phenylbutazone na mgbe ọpụpụ,
ethanol: ị ofụ ihe ọholicụ orụ na-aba n'anya ma ọ bụ ọgwụ ethanol nwere ọgwụ na-egbochi mmeghachi ụgwọ, nke nwere ike ibute ịba ụba hypoglycemia ma ọ bụ mmepe nke hypoglycemic coma,
ndị ọzọ hypoglycemic (insulin, acarbose, metformin, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists), beta-blockers, fluconazole, angiotensin na-agbanwe enzyme inhibitors (ndị na-egbochi ndị na-egbochi, ndị na-egbochi enna).₂Ndị na-anabata yahistamine, monoamine oxidase inhibitors, sulfonamides, clarithromycin, ọgwụ mgbochi na - abụghị steroid: mmonye nke ọgwụ ndị a na glycazide na - esochi mmụba nke ọrụ Golda MV yana oke ihe ize ndụ nke hypoglycemia,
danazol: mmetụta diabetogenic nke danazol na-enyere aka belata ihe omume nke gliclazide,
chlorpromazine: usoro ọgwụ kwa ụbọchị dị elu (ihe karịrị 100 mg) nke chlorpromazine na-ebelata insulin na-akpata, na-eme ka mmụba n'ọbara glucose ọbara. Ya mere, site na iji ọgwụ mgbochi concoitant antipsychotic, nhọrọ nke dose nke gliclazide na njikwa glycemic, gụnyere mgbe ịkwụsị chlorpromazine gasịrị, achọrọ,
tetracosactide, GCS maka usoro na usoro eji: belata nnabata carbohydrate, na-enye aka na mmụba nke glycemia na ihe ize ndụ nke ịmalite ketoacidosis. Achọrọ iji nlezianya nyochaa ọkwa glucose ọbara, karịchaa mmalite nke ọgwụgwọ nkwonkwo, ma ọ bụrụ na ọ dị mkpa, ndozi nke gliclazide,
ritodrin, salbutamol, terbutaline (iv): ekwesiri iburu n'uche na beta₂-adrenomimetik na-eme ka glucose dị n'ọbara, yabụ, mgbe ha jikọtara ha, ndị ọrịa chọrọ njide onwe glycemic oge niile, ọ ga-ekwe omume ịnyefe onye ọrịa na ọgwụgwọ insulin,
warfarin na ọgwụ anticoagulants ndị ọzọ: gliclazide nwere ike itinye aka na mmụba dị ukwuu na-emetụta ọgwụgwọ nke anticoagulants.

Analogs nke Golda MV bụ: Diabetalong, Glidiab, Gliclada, Gliclazide Canon, Gliclazide MV, Gliclazide-SZ, Gliclazide-Akos, Diabeton MB, Diabinax, Diabefarm, Diabefarm MV, wdg.

Nyocha banyere Gold MV

Nyocha banyere Gold MV bụ arụmụka. Ndị ọrịa (ma ọ bụ ndị ikwu ha) na-egosi nsonaazụ ngwa ngwa nke ike iwetulata shuga ka ha na-a theụ ọgwụ ahụ, ebe enwere ọghọm hypoglycemia na mmetụta ndị ọzọ. Na ntinye, a na-ewere ọnụnọ nke contraindications dị ka ọghọm.

N'oge nchịkwa nke Golda MV, a na-atụ aro ka o lezie anya usoro nri na usoro edozi, njikwa shuga ọbara kwa ụbọchị.